Why is Venmax Drugs falling/rising?

As of 26-Sep, Venmax Drugs & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 22.10, which represents a decrease of Rs 1.14 or 4.91%. The stock has underperformed its sector by 2.57% today and has been on a consecutive downward trend for the last two days, resulting in a total decline of 7.57% during this period. The stock opened significantly lower today, with a loss of 4.99%, and has traded below its moving averages across various time frames. Additionally, the stock's performance over the past week and month shows a steep decline of 16.29% and 36.13%, respectively, indicating a challenging period for the company. There is no information available regarding positive or negative factors affecting the stock.
Broader Market Context: In comparison to the benchmark Sensex, which has decreased by 2.66% over the past week and 0.45% over the past month, Venmax Drugs' performance has been significantly worse, highlighting its struggles in the current market environment. The pharmaceuticals and drugs sector has also seen a decline of 2.35%, contributing to the negative sentiment surrounding Venmax Drugs. Furthermore, a notable drop in investor participation, with delivery volume falling by 60.43% against the five-day average, suggests a lack of confidence among investors, which may be influencing the stock's downward trajectory.